Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
J INTS BIO Gives Presentation of Phase 1/2 study of 'JIN-A02', a Novel Oral 4th Generation EGFR TKI, at ESMO Asia 2023 2023-12-05 15:16
Clarivate Expands Partnership with VeriSIM Life to Accelerate and De-risk Research and Drug Development 2023-12-05 15:00
Insilico Medicine Announces First-in-Human Study for Orally PHD Inhibitor ISM5411 for Inflammatory Bowel Disease (IBD) 2023-12-05 06:00
CARsgen's CT071 Received IND Clearance from the FDA for Treating Relapsed/Refractory Multiple Myeloma or Relapsed/Refractory Primary Plasma Cell Leukemia 2023-12-04 21:50
Technoderma Medicines Completes Phase 1 Dose Escalation Clinical Trial of TDM-180935 for Atopic Dermatitis 2023-12-04 21:13
Abbisko Therapeutics Announced the Entry into a Licensing Agreement for Pimicotinib (ABSK021) with Merck 2023-12-04 21:05
Mootral introduces new methane reduction technology, doubling efficacy using a well-known natural molecule 2023-12-04 20:00
Latest Updates of Viva's Portfolio Companies 2023-12-04 17:55
Supercell Acquires Exclusive Licensing from Japanese Immunotherapy Leader for Advanced NK Cell Treatment Technology 2023-12-04 16:39
Nona Biosciences Announces Collaboration Agreement with Lycia Therapeutics 2023-12-04 13:19
Everest Medicines Announces Investigational New Drug Application Acceptance of Zetomipzomib in China 2023-12-04 08:58
280Bio doses first patient in Phase I clinical trial of TEB-17231, an oral pan-RAS inhibitor in patients with advanced cancers harboring mutations in KRAS, HRAS, or NRAS 2023-12-01 21:00
GC Biopharma establishes mRNA production facility in Hwasun, Korea 2023-12-01 16:31
Innovent Presents Clinical Data Update of IBI351 (KRAS G12C Inhibitor) Monotherapy in Lung Cancer and Colorectal Cancer at ESMO Asia Congress 2023 2023-12-01 12:00
Cerecin forges strategic partnership with A*STAR's Institute of Molecular and Cell Biology (IMCB) in Singapore to advance R&D in neurological disorders. 2023-12-01 09:34
Everest Medicines Announces Positive Topline Results from Induction Period of Etrasimod Phase 3 Clinical Trial Conducted in Asia for the Treatment of Moderate-to-Severe Active Ulcerative Colitis 2023-12-01 07:33
Biocon Biologics Successfully Completes Integration of Viatris' Biosimilar Business in 31 Countries in Europe 2023-12-01 03:53
CABIO unveils NeoHMOs™ series at FIE 2023, targeting growing global demand for infant formula 2023-11-30 21:00
Peptone and The Institute of Oncology Research (IOR) Bellinzona Announce Collaborative Research Agreement 2023-11-30 20:00
Phase II OPALESCENCE Study of TLX250-CDx in Triple Negative Breast Cancer to be Presented at SABCS 2023-11-30 04:15
1 29 30 31 32 33 415